MLT II (Melanotan II) – 20mg

Comprehensive Laboratory Profile

The acquisition of targeted, non-selective melanocortin receptor agonists provides institutional laboratories with the advanced capability to observe broad-spectrum cellular signaling and melanocyte activation in real-time. By integrating the MLT II 20mg peptide into institutional protocols, researchers gain access to a highly purified, concentrated formulation engineered to simulate aggressive binding across multiple MC receptor pathways.

Synthesized within the USA to the most rigorous industry standards, this specialized complex delivers absolute analytical precision. Utilizing the MLT II 20mg formulation ensures your laboratory acquires reproducible data, free from the rapid enzymatic degradation typically associated with native alpha-melanocyte-stimulating hormone ($\alpha$-MSH).

Biochemical Profile: Non-Selective MC Receptor Agonist

The MLT II formulation is a synthetically engineered, cyclic, lactam-bridged heptapeptide. Unlike MLT I (which is a linear peptide primarily selective for the MC1 receptor), MLT II is a truncated, structurally rigid analog that exhibits potent, non-selective agonist activity.

This cyclic structure renders the peptide highly resistant to proteolytic cleavage. By introducing the MLT II 20mg matrix into an in-vitro environment, researchers can evaluate sustained activation across a broad spectrum of melanocortin receptors, most notably MC1R (associated with pigmentation), MC3R, and MC4R (associated with energy homeostasis and sexual arousal signaling pathways).

Mechanism of Action in Cellular Assays

When introduced to cellular monolayers or complex tissue cultures, the MLT II 20mg compound functions as a synchronized, multi-receptor trigger. It actively binds to the extracellular domains of melanocortin receptors, initiating a robust intracellular cascade that significantly elevates cyclic AMP (cAMP) levels.

At the MC1R site, this cAMP up-regulation rapidly stimulates the transcription of tyrosinase, driving eumelanin synthesis. Simultaneously, in neurological or metabolic cell models, its interaction with MC4R allows researchers to map pathways related to metabolic expenditure and appetite down-regulation. By deploying this high-concentration 20mg formulation, laboratories can establish highly stable micro-environments where multi-pathway signaling can be monitored with total scientific clarity.

Primary In-Vitro Research Applications

The exceptional purity and rigid cyclic design of this peptide make it a cornerstone for complex dermatological, metabolic, and neuro-endocrine R&D:

• Broad-Spectrum MC Binding Assays: Mapping the kinetic response and affinity rates across MC1R, MC3R, and MC4R models.

• Melanogenesis Studies: Evaluating the precise activation of tyrosinase and eumelanin production in melanocyte cultures.

• Energy Homeostasis Modeling: Utilizing the MLT II 20mg complex to monitor cellular metabolic shifts mimicking MC4R-driven anorexigenic responses.

• Receptor Selectivity R&D: Using this non-selective analog to establish standardized baseline data for comparative efficacy testing against highly specific, single-receptor target peptides.

Absolute Purity and Quality Assurance

At Ion Peptides, we recognize that anomalous data caused by degraded or structurally compromised substrates critically jeopardizes institutional research funding. Every single batch of our MLT II 20mg peptide is subjected to uncompromising third-party analytical testing before being approved for acquisition.

We utilize High-Performance Liquid Chromatography (HPLC) to verify a purity threshold of >99.0%. Furthermore, rigorous Mass Spectrometry (MS) confirms the precise cyclic structural sequence and integrity of the complex. By securing your supply through our secure USA synthesis network and utilizing our encrypted crypto payment gateways, you guarantee your facility receives elite, uncompromised materials.

Lyophilization, Storage, and Reconstitution Protocols

To ensure maximum molecular stability during secure domestic transit, the MLT II 20mg vial is supplied as a lyophilized (freeze-dried) solid powder.

• Storage: Keep vials in a climate-controlled, dark environment, ideally at or below -20°C. Protected from light and moisture, the unmixed powder remains stable for up to 36 months.

• Reconstitution: Utilize sterile bacteriostatic water.

  1. Allow the vial to reach ambient room temperature to prevent condensation.

  2. Introduce the diluent slowly, directing the fluid flow down the inner wall of the glass to prevent sheer stress.

  3. Do not agitate or vortex the vial. Allow the MLT II 20mg powder to dissolve naturally into a clear solution via gentle swirling.

  4. Once reconstituted, refrigerate immediately at 2°C to 8°C and utilize within standard laboratory protocol timelines.